# Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19

> **NCT05007496** · PHASE2 · COMPLETED · sponsor: **Aivita Biomedical, Inc.** · enrollment: 145 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** AV-COVID-19

## Key facts

- **NCT ID:** NCT05007496
- **Lead sponsor:** Aivita Biomedical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-14
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2021-08-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05007496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05007496, "Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05007496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*